Lifeward Ltd. announced on June 26, 2025, the closing of its previously announced public offering. The offering generated aggregate gross proceeds of approximately $2.6 million for the company, before deducting placement agent fees and other offering expenses.
The offering included 4,000,000 ordinary shares and accompanying warrants to purchase up to 4,000,000 ordinary shares, at a combined public offering price of $0.65 per ordinary share and associated ordinary warrant.
The net proceeds from this offering are intended for continuing commercial efforts, working capital, and general corporate purposes. This capital infusion supports Lifeward's ongoing operations and strategic initiatives.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.